Selected Important Safety Information

What is the most important information I should know about Victoza^®?
Victoza^® may cause serious side effects, including:

Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Victoza^® and medicines that work like Victoza^® caused thyroid tumors, including thyroid cancer. It is not known if Victoza^® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.

Who should not use Victoza^®?
Do not use Victoza^® if:

you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
you are allergic to liraglutide or any of the ingredients in Victoza^®.

Please see additional Important Safety Information for Victoza^®.

Someone you know may be interested in learning more about Tresiba^®(insulin degludec injection). Simply complete all the fields below and then submit to share this information.

I thought you may be interested in learning more about Tresiba^® (insulin degludec injection 100 Units/mL, 200 Units/mL), a long-acting basal insulin for adults and children as young as 1 year of age with diabetes that is taken once a day to help control blood sugar.

You can find out more about Tresiba^® at www.Tresiba.com. You will also find information about diabetes and insulin, tools and tips for diabetes care, and details about Tresiba^® FlexTouch^®, the latest prefilled insulin pen from Novo Nordisk with no push-button extension.

Email addresses are used for this mailing request only and are not saved by Tresiba.com or Novo Nordisk for any other purposes.

What is Tresiba^®?

Prescription Tresiba^® is a long-acting insulin used to control high blood sugar in adults and children who are 1 year of age and older with diabetes
Tresiba^® is not for people with diabetic ketoacidosis
Tresiba^® is not for children who need less than 5 units of Tresiba^® each day
It is not known if Tresiba^® is safe and effective in children under 1 year of age
Tresiba^® is available in 2 concentrations: 200 units/mL and 100 units/mL

Important Safety Information

Do not share your Tresiba^® FlexTouch^® with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

Who should not take Tresiba^®?

Do not take Tresiba^® if you:

are having an episode of low blood sugar
are allergic to Tresiba^® or any of the ingredients in Tresiba^®

Before taking Tresiba^®, tell your health care provider about all your medical conditions, including if you are:

pregnant, planning to become pregnant, or are breastfeeding
taking new prescription or over-the-counter medicines, vitamins, or herbal supplements

Talk to your health care provider about low blood sugar and how to manage it.

How should I take Tresiba^®?

Read the Instructions for Use and take Tresiba^® exactly as your health care provider tells you to
Do not do any conversion of your dose. The dose counter always shows the selected dose in units
Know the type and strength of insulin you take. Do not change the type of insulin you take unless your health care provider tells you to
Adults - If you miss or are delayed in taking your dose of Tresiba^®:
- Take your dose as soon as you remember, then continue with your regular dosing schedule
- Make sure there are at least 8 hours between doses
If children miss a dose of Tresiba^®:
- Call the healthcare provider for information and instructions about checking blood sugar levels more often until the next scheduled dose of Tresiba^®
Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them
Do not reuse or share your needles with other people. You may give them a serious infection, or get a serious infection from them
Never inject Tresiba^® into a vein or muscle
Never use a syringe to remove Tresiba^® from the FlexTouch^® pen

What should I avoid while taking Tresiba^®?

Do not drive or operate heavy machinery, until you know how Tresiba^® affects you
Do not drink alcohol or use prescription or over-the-counter medicines that contain alcohol

What are the possible side effects of Tresiba^®?

Tresiba^® may cause serious side effects that can be life-threatening, including:

Low blood sugar (hypoglycemia). Signs and symptoms that may indicate low blood sugar include anxiety, irritability, mood changes, dizziness, sweating, confusion, and headache
Low potassium in your blood (hypokalemia)
Heart failure in some people if taken with thiazolidinediones (TZDs). This can happen even if you have never had heart failure or heart problems. If you already have heart failure, it may get worse while you take TZDs with Tresiba^®. Tell your health care provider if you have any new or worse symptoms of heart failure including shortness of breath, tiredness, swelling of your ankles or feet, and sudden weight gain

Your insulin dose may need to change because of change in level of physical activity or exercise, increased stress, change in diet, weight gain or loss, or illness.

Common side effects may include reactions at the injection site, itching, rash, serious allergic reactions (whole body reactions), skin thickening or pits at the injection site (lipodystrophy), weight gain, and swelling of your hands and feet.

Get emergency medical help if you have trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.

Please click here for Tresiba^® Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Tresiba^® is a prescription medication.

If you need assistance with prescription costs, help may be available. Visit www.pparx.org or call 1-888-4PPA-NOW.

FlexTouch^® and Tresiba^® are registered trademarks of Novo Nordisk A/S.

Novo Nordisk is a registered trademark of Novo Nordisk A/S.

Selected Important Safety Information

What is the most important information I should know about Victoza^®?
Victoza^® may cause serious side effects, including:

Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Victoza^® and medicines that work like Victoza^® caused thyroid tumors, including thyroid cancer. It is not known if Victoza^® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.

Who should not use Victoza^®?
Do not use Victoza^® if:

you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
you are allergic to liraglutide or any of the ingredients in Victoza^®.

Please see additional Important Safety Information for Victoza^®.

WATCH VIDEOS

Learn about Tresiba^® FlexTouch^® and how diabetes and insulin affect your body

WATCH VIDEOS

Learn about Tresiba^® FlexTouch^® and how diabetes and insulin affect your body

How to Use Tresiba^® U‑200 FlexTouch^®

If you like to learn by watching, this video can guide you on how to use Tresiba^® FlexTouch^®. This video provides step-by-step instructions for the Tresiba^® U-200 FlexTouch^®.